Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Pharmacyclics, an AbbVie CompanyPharmacyclics, an AbbVie Company
VS
MerckMerck
Pharmacyclics, an AbbVie Company

Pharmacyclics, an AbbVie Company

999 East Arques Avenue, Sunnyvale, 94085, US

Last Update: 03/04/2026

View Profile
Between 750 and 799
http://www.pharmacyclics.com
756/1000Fair

Pharmacyclics is committed to the development and commercialization of novel therapies intended to improve the quality and duration of life and to resolve serious unmet medical needs for cancer patients. Pharmacyclics is a wholly-owned subsidiary of AbbVie (NYSE:ABBV), ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:613
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0
Merck

Merck

126 E Lincoln Ave, P.O. Box 2000, Rahway, New Jersey, US, 07065

Last Update: 05/07/2026

View Profile
Between 800 and 849
http://merck.us/2J2xAUh
802/1000Good

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of i...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:44,762
Subsidiaries:2
12-month incidents
0
Known data breaches
1
Attack type number
2

Compliance Ranges Comparison

Based On Specific Ai Models Category
Pharmacyclics, an AbbVie Company

Pharmacyclics, an AbbVie Company

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Merck

Merck

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Pharmacyclics, an AbbVie Company in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Merck in 2026.

Incidents

Incident History - Pharmacyclics, an AbbVie Company (X = Date, Y = Severity)

Pharmacyclics, an AbbVie Company cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Merck (X = Date, Y = Severity)

Merck cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Pharmacyclics, an AbbVie Company

Pharmacyclics, an AbbVie Company

Incidents
No explicit notable incidents reported.
Merck

Merck

Incidents
🔒 Incident : Breach
MER3502435111825
🔒 Incident : Cyber Attack
MER1775377932
🔒 Incident : Cyber Attack
MER1502422

FAQ

Between Pharmacyclics, an AbbVie Company company and Merck company, which one has the best AI Cybersecurity Score ?
Between Pharmacyclics, an AbbVie Company company and Merck company, which one has experienced more cyber incidents in the past ?
Between Pharmacyclics, an AbbVie Company company and Merck company, which one has experienced more cyber incidents this year ?
Between Pharmacyclics, an AbbVie Company company and Merck company, which one has experienced at least one ransomware attack ?
Between Pharmacyclics, an AbbVie Company company and Merck company, which one has experienced at least one data breach ?
Between Pharmacyclics, an AbbVie Company company and Merck company, which one has experienced at least one targeted cyberattack ?
Between Pharmacyclics, an AbbVie Company company and Merck company, which one has experienced at least one vulnerability ?
Between Pharmacyclics, an AbbVie Company company and Merck company, which one holds the most compliance certifications ?
Between Pharmacyclics, an AbbVie Company company and Merck company, which one holds the fewest compliance certifications ?
Between Pharmacyclics, an AbbVie Company company and Merck company, which one has the most subsidiaries ?
Between Pharmacyclics, an AbbVie Company company and Merck company, which one has the largest number of employees ?
Between Pharmacyclics, an AbbVie Company and Merck, which company holds both SOC 2 Type 1 certifications ?
Between Pharmacyclics, an AbbVie Company and Merck, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Pharmacyclics, an AbbVie Company or Merck ?
Which company is PCI DSS compliant - Pharmacyclics, an AbbVie Company or Merck ?
Between Pharmacyclics, an AbbVie Company and Merck, which company complies with HIPAA regulations for healthcare data ?
Between Pharmacyclics, an AbbVie Company and Merck, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-45537
SUMMARY

OpenSIPS is a Session Initiation Protocol (SIP) server implementation. In versions prior to 3.6.6 and 4.0.0-rc1, the construct_uri() function concatenates multiple URI components (protocol, username, domain, port, params) into a fixed 1024-byte global BSS buffer without any bounds checking. When a routing script calls construct_uri() with an attacker-controlled username, a combined component length exceeding 1024 bytes overflows the buffer, corrupting adjacent global data with attacker-controlled content. The overflow reaches disable_503_translation, a global flag controlling SIP 503 response handling, allowing an attacker to deterministically set the flag via the URI username and alter the server's routing behavior for subsequent messages. Because the same buffer is shared with contact_builder(), the overflow also corrupts that function's data, and without a memory sanitizer the adjacent globals are silently overwritten on every request containing a long username. This issue has been fixed in versions 3.6.6 and 4.0.0-rc1.

PUBLISHED
Date2026-08-04
UPDATED
Date2026-08-04
RISK INFORMATION (Score: 9.1)
CVSS3
Base Score: 9.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:H
IMPACT SCORE
5.2
EXPLOITABILITY
3.9
CVE-2026-18819
SUMMARY

A security vulnerability has been detected in RackTables up to 0.22.0/e5fff9f8aab339798ed47e8c6d7d977ed97a82bd. This vulnerability affects unknown code. The manipulation leads to cross-site request forgery. The attack is possible to be carried out remotely. The exploit has been disclosed publicly and may be used. The project maintainer confirms: "[I]t seems plausible, in that RackTables does not at this time have any CSRF prevention. You may assign a CVE ID to this, but there is no guarantee it will be handled in urgent, or even timely, manner, or at all."

PUBLISHED
Date2026-08-04
UPDATED
Date2026-08-04
RISK INFORMATION (Score: 4.3)
CVSS2
Base Score: 5.0
Complexity: LOW
AV:N/AC:L/Au:N/C:N/I:P/A:N
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-18818
SUMMARY

A weakness has been identified in Ehco1996 django-sspanel up to 2023.12.26. This affects the function TicketDetailView of the file apps/sspanel/views.py of the component Support Ticket Handler. Executing a manipulation can lead to authorization bypass. The attack can be executed remotely. The vendor was contacted early about this disclosure but did not respond in any way. This vulnerability only affects products that are no longer supported by the maintainer.

PUBLISHED
Date2026-08-04
UPDATED
Date2026-08-04
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-70620
SUMMARY

Odysseus before commit 87babb5 contains a server-side request forgery vulnerability that allows admin-privileged attackers to direct the server to probe internal network resources by supplying arbitrary URLs to the embedding endpoint configuration without scheme, host, IP range, or DNS rebind validation. Attackers can submit loopback addresses, RFC 1918 ranges, or link-local addresses through the embedding endpoint API to partially read responses from cloud instance metadata services, internal APIs, and other hosts reachable from the server.

PUBLISHED
Date2026-08-04
UPDATED
Date2026-08-04
RISK INFORMATION (Score: 6.8)
CVSS3
Base Score: 6.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:N/A:N
CVSS4
Base Score: 6.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:N/SC:H/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4
EXPLOITABILITY
2.3
CVE-2026-70619
SUMMARY

Odysseus before commit bf325f6 contains a missing authorization vulnerability that allows authenticated non-admin users to manage server-wide embedding backend configuration by invoking endpoint management routes that verify session authentication but omit the admin authorization guard. Attackers can supply an attacker-controlled URL to overwrite the embedding backend persisted in the endpoint configuration file and process environment, causing all subsequent embedding operations including chat messages, RAG queries, memory entries, and vault text to be transmitted in plaintext to the attacker-controlled destination, or delete the endpoint configuration to deny embedding service to all users.

PUBLISHED
Date2026-08-04
UPDATED
Date2026-08-04
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8